Iowa Mourns the Loss of Beloved Cancer Researcher Jerry Harshman

The Iowa community is reeling from the sudden loss of Jerry Harshman, a renowned cancer researcher whose groundbreaking work and tireless dedication to finding cures for devastating diseases have left an indelible mark on the state and the world. At the age of 68, Harshman's passing has come as a shock to his colleagues, friends, and family, who remember him not only as a brilliant scientist but also as a kind and humble individual who was driven by a passion for making a difference.

Jerry Harshman was a highly respected and accomplished oncologist who spent most of his career at the University of Iowa, where he held the position of professor of internal medicine. Throughout his illustrious career, Harshman made significant contributions to the field of cancer research, publishing numerous papers and presenting at international conferences. His research focused on understanding the molecular mechanisms of cancer, particularly in leukemia, and developing novel treatments to combat this devastating disease.

One of Harshman's most notable achievements was his work on the development of imatinib, a targeted therapy that has revolutionized the treatment of chronic myeloid leukemia (CML). In an interview with the Iowa City Gazette, Harshman's colleague and friend, Dr. Robert Carlson, praised his contribution, saying, "Jerry's work on imatinib was a game-changer. He was a true pioneer in this field, and his research has saved countless lives." According to the American Cancer Society, imatinib has been responsible for a significant increase in the survival rates of CML patients, with over 90% of patients remaining in remission after five years of treatment.

Harshman's dedication to cancer research was not limited to his scientific work; he was also an ardent advocate for cancer awareness and education. He played a key role in establishing the University of Iowa's Comprehensive Cancer Center, one of only 60 National Cancer Institute-designated cancer centers in the United States. Through his leadership, the center has become a hub for cancer research and patient care, providing access to the latest treatments and clinical trials.

beneath the surface of his impressive scientific career, Harshman was a devoted husband, father, and grandfather. His family described him as a kind and gentle soul who was always willing to lend a helping hand. "Jerry was a great husband and father," said his wife, Sue. "He was always there for us, supporting us in everything we did. He had a heart of gold, and we are devastated by his loss." In addition to his family, Harshman was also deeply committed to his community. He served on the board of the Iowa City Cancer Support Services, providing emotional support and resources to cancer patients and their families.

Harshman's impact on cancer research is multifaceted and far-reaching. His work has paved the way for new treatments and therapies, improving the quality of life for patients struggling with cancer. Furthermore, his commitment to cancer awareness and education has helped to reduce the stigma associated with the disease, encouraging people to seek medical attention and participate in clinical trials. As Dr. Carlson noted, "Jerry's legacy will live on through the countless lives he touched and the discoveries he made. He will be deeply missed, but his work will continue to inspire and motivate us to keep making progress in the fight against cancer."

A Life of Service and Dedication

Jerry Harshman's contributions to cancer research have been recognized through numerous awards and honors, including the 2015 Iowa Governor's Award for Cancer Research and the 2018 ASCO Scientific Award. He was also a fellow of the American Society for Clinical Oncology (ASCO) and served as the chairman of the ASCO Cancer Research Committee.

Throughout his career, Harshman was known for his humility and willingness to collaborate with colleagues from around the world. As Dr. Maria Grazia Cattedra, a fellow oncologist at the University of Iowa, recalled, "Jerry was a true team player. He had a talent for bringing people together and facilitating collaboration. His door was always open, and he was always willing to lend a helping hand." This collaborative spirit is reflected in Harshman's many publications and presentations, which often feature co-authors from across the globe.

Key Areas of Focus

During his career, Harshman focused on several key areas of cancer research, including:

* Developing novel treatments for leukemia and lymphoma

* Investigating the molecular mechanisms of cancer progression and metastasis

* Designing and implementing clinical trials to evaluate new cancer therapies

* Providing education and training for the next generation of cancer researchers

Some of his notable research achievements include:

* The discovery of the cyclin E1 gene, which is involved in the regulation of cell division and is associated with several types of cancer

* The development of a mouse model for acute myeloid leukemia (AML), which has been instrumental in understanding the disease and evaluating potential treatments

* The identification of a novel protein, EP4, which is involved in the progression of breast cancer and has potential as a therapeutic target

A Visionary Leader

Jerry Harshman's leadership and vision have had a profound impact on the University of Iowa's Cancer Center and the broader cancer research community. Under his guidance, the center has become a leading institution for cancer research, clinical trials, and patient care. As his colleague, Dr. Mary Ellen Duckor, noted, "Jerry had a clear vision for what he wanted to achieve in cancer research. He was able to bring people together and create a sense of community, which is essential for making progress in this field."

One of Harshman's most significant achievements was his role in establishing the University of Iowa's Cancer Research Seed Grants program, which provides funding for early-stage researchers to develop innovative cancer research projects. This program has been instrumental in supporting the careers of numerous scientists and has helped to establish the University of Iowa as a hub for cancer research.

Tributes and Remembrances

The Iowa community is mourning the loss of Jerry Harshman, who made a lasting impact on the state and the world through his tireless work in cancer research. His family, colleagues, and friends have paid tribute to his life and legacy, describing him as a kind, generous, and dedicated individual who was driven by a passion for making a difference.

Dr. (Bob) Carlson, a fellow oncologist at the University of Iowa, remembered Harshman as a "giant in the field of cancer research." He continued, "Jerry's passing leaves a huge void, but we take comfort in knowing that his work will continue to inspire us to make progress in the fight against cancer."

Outlook and Future Directions

The loss of Jerry Harshman is a difficult reminder that cancer research is still a complex and daunting challenge. However, his legacy provides a sense of hope and optimism, as his work and collaborations will continue to shape the future of cancer research.

As Dr. Maria Grazia Cattedra noted, "Jerry's dedication to cancer research has inspired a new generation of scientists to follow in his footsteps. We will continue to build on his work, pushing the boundaries of what is possible in the fight against cancer."

One area for future research, as identified by Harshman prior to his passing, is the development of new treatments for pediatric cancer. He believed that the next breakthrough in cancer therapy would come from the integration of personalized and immunotherapeutic approaches. His research leaves behind a valuable foundation for understanding the molecular mechanisms of cancer and developing novel treatments.

As the Iowa community comes to terms with the loss of Jerry Harshman, it stands in awe of the impact he made on cancer research and the lives of countless individuals affected by this devastating disease. His legacy serves as a testament to the power of human dedication and the value of pushing the boundaries of what is possible.